Development of a GPCR-binding ligand screening method using real-time interaction analysis on live cells
Abstract
Background and Purpose: G protein-coupled receptors (GPCRs) affect many physiological processes, and their dysfunction is related to a wide range of diseases and are thus frequently used as drug targets and biomarkers. The present study focuses on the neurokinin 1 receptor (NK1-R) which is over-expressed on neural tumours with the aim to develop high affinity binders to NK1-R for theranostic purposes. 60 Ligands were synthesized, all containing iodine enabling isotopic exchange with radioactive iodine for imaging or radiotherapeutic applications. Experimental Approach: Embedded in the cellular membrane, GPCRs adopt various conformational states that can change upon interaction with agonistic or antagonistic ligands. To screen ligands, a time-resolved, live cell assay was developed to evaluate competition with fluorescently labelled endogenous NK1-R ligand, Substance P (FAM-SP). Key Results: The time resolved assay enabled quantification of the efficiency in which the ligands compete for the rapid and slow releasing NK1-R binding modes of FAM-SP. 25 Ligands were able to displace FAM-SP faster than the anti-nausea drug aprepitant. Two of these ligands displaced the rapid releasing FAM-SP fraction faster than Substance P (SP) and one of them also replaced the slow releasing fraction faster than aprepitant. To validate the assay, the affinity of two ligands for several NK1-R expressing cell lines was further quantified; one that had similar competition characteristics as SP and one that behaved as aprepitant. Conclusion and Implications: The ligand with similar competition characteristics as SP displayed a low nM to sub-pM affinity with a stronger binding correlating with higher receptor expression levels. This high affinity makes it a highly promising candidate for further development into a theranostic agent to address neural tumours.